Catalog No.
PHJ02101
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human EPHA10 (Val645-Gly888).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
EPHA10,Ephrin type-A receptor 10
Purification
Purified by antigen affinity column.
Accession
Q5JZY3
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer., PMID:35278434
[Development of a Fundamental Technology to Seek Drug Targets, and Its Application to Cancer Targeting Therapy]., PMID:29962467
Overcoming Multidrug Resistance by Codelivery of MDR1-Targeting siRNA and Doxorubicin Using EphA10-Mediated pH-Sensitive Lipoplexes: In Vitro and In Vivo Evaluation., PMID:29798663
Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA., PMID:27574425
[Challenge to the Development of Molecular Targeted Therapy against a Novel Target Candidate Identified by Antibody Proteomics Technology]., PMID:26831784
A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy., PMID:26678395
Generation and characterization of a bispecific diabody targeting both EPH receptor A10 and CD3., PMID:25528586
Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers., PMID:24946238
Eph receptor A10 has a potential as a target for a prostate cancer therapy., PMID:24924629
For research use only. Not for human or drug use.
